why choose us

First received: February 06, 2026

Clinical Trial: How [14C]-DSP-5336 is Absorbed, Broken Down, and Removed From the Body After a Single Oral Dose in Patients With Advanced Blood Cancers

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Advanced Hematologic Malignancies

Study Type: INTERVENTIONAL


Official Title: A Phase 1, Open-label Study of the Absorption, Metabolism, and Excretion of DSP-5336 Following a Single Oral Dose in Patients With Refractory or Relapsed Acute Leukemia, Myelodysplastic Syndrome, Mult

Brief Summary: The purpose of this study is to evaluate the absorption, metabolism, and excretion of DSP-5336 following a single oral administration of the study drug in patients with hematologic malignancies whose disease has progressed after available standard therapies.

Read more